4zks

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (08:35, 9 October 2024) (edit) (undo)
 
(2 intermediate revisions not shown.)
Line 1: Line 1:
==The crystal structure of upain-1-W3A in complex with inactive uPA (uPA-S195A) at pH7.4==
==The crystal structure of upain-1-W3A in complex with inactive uPA (uPA-S195A) at pH7.4==
-
<StructureSection load='4zks' size='340' side='right' caption='[[4zks]], [[Resolution|resolution]] 1.85&Aring;' scene=''>
+
<StructureSection load='4zks' size='340' side='right'caption='[[4zks]], [[Resolution|resolution]] 1.85&Aring;' scene=''>
== Structural highlights ==
== Structural highlights ==
-
<table><tr><td colspan='2'>[[4zks]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4ZKS OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4ZKS FirstGlance]. <br>
+
<table><tr><td colspan='2'>[[4zks]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] and [https://en.wikipedia.org/wiki/Synthetic_construct Synthetic construct]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4ZKS OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4ZKS FirstGlance]. <br>
-
</td></tr><tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4zkn|4zkn]], [[4zko|4zko]], [[4zkr|4zkr]]</td></tr>
+
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.85&#8491;</td></tr>
-
<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/U-plasminogen_activator U-plasminogen activator], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.21.73 3.4.21.73] </span></td></tr>
+
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4zks FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4zks OCA], [https://pdbe.org/4zks PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4zks RCSB], [https://www.ebi.ac.uk/pdbsum/4zks PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4zks ProSAT]</span></td></tr>
-
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4zks FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4zks OCA], [http://pdbe.org/4zks PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4zks RCSB], [http://www.ebi.ac.uk/pdbsum/4zks PDBsum]</span></td></tr>
+
</table>
</table>
== Disease ==
== Disease ==
-
[[http://www.uniprot.org/uniprot/UROK_HUMAN UROK_HUMAN]] Defects in PLAU are the cause of Quebec platelet disorder (QPD) [MIM:[http://omim.org/entry/601709 601709]]. QPD is an autosomal dominant bleeding disorder due to a gain-of-function defect in fibrinolysis. Although affected individuals do not exhibit systemic fibrinolysis, they show delayed onset bleeding after challenge, such as surgery. The hallmark of the disorder is markedly increased PLAU levels within platelets, which causes intraplatelet plasmin generation and secondary degradation of alpha-granule proteins.<ref>PMID:20007542</ref>
+
[https://www.uniprot.org/uniprot/UROK_HUMAN UROK_HUMAN] Defects in PLAU are the cause of Quebec platelet disorder (QPD) [MIM:[https://omim.org/entry/601709 601709]. QPD is an autosomal dominant bleeding disorder due to a gain-of-function defect in fibrinolysis. Although affected individuals do not exhibit systemic fibrinolysis, they show delayed onset bleeding after challenge, such as surgery. The hallmark of the disorder is markedly increased PLAU levels within platelets, which causes intraplatelet plasmin generation and secondary degradation of alpha-granule proteins.<ref>PMID:20007542</ref>
== Function ==
== Function ==
-
[[http://www.uniprot.org/uniprot/UROK_HUMAN UROK_HUMAN]] Specifically cleaves the zymogen plasminogen to form the active enzyme plasmin.
+
[https://www.uniprot.org/uniprot/UROK_HUMAN UROK_HUMAN] Specifically cleaves the zymogen plasminogen to form the active enzyme plasmin.
 +
 
 +
==See Also==
 +
*[[Plasminogen activator|Plasminogen activator]]
 +
*[[Urokinase 3D Structures|Urokinase 3D Structures]]
== References ==
== References ==
<references/>
<references/>
__TOC__
__TOC__
</StructureSection>
</StructureSection>
-
[[Category: U-plasminogen activator]]
+
[[Category: Homo sapiens]]
-
[[Category: Andreasen, P A]]
+
[[Category: Large Structures]]
-
[[Category: Huang, M]]
+
[[Category: Synthetic construct]]
-
[[Category: Jiang, L]]
+
[[Category: Andreasen PA]]
-
[[Category: Hydrolase-hydrolase inhibitor complex]]
+
[[Category: Huang M]]
-
[[Category: Peptides inhibitor]]
+
[[Category: Jiang L]]
-
[[Category: Serine protease]]
+
-
[[Category: Upa]]
+

Current revision

The crystal structure of upain-1-W3A in complex with inactive uPA (uPA-S195A) at pH7.4

PDB ID 4zks

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools